Conference abstract · 29 Aug 2018
OpinionPublished 3 Feb 2025
Oligonucleotide-Based Therapies in Hematologic Malignancies
Subjects
HaematologySimilar by topic
Conference abstract · 2 Oct 2017
Gene-specific enhancement of protein synthesis by targeting 5’UTRs -A novel oligonucleotide-based strategy for translational control of selected tumor suppressors
Conference abstract · 2018
When do we stop? Modern sequential therapies for hematologic malignancies and end of life questions
Conference abstract · 29 Jun 2017
Potent anti-leukemia activities of chimeric antigen receptor modified T (CAR-T) cell therapy in Chinese patients with relapsed/refractory hematological malignances
Conference abstract · 8 May 2017
Incidence, natural history and outcome of targeted therapy-induced cardiotoxicity in hematologic malignancy (HM) patients
More from this journal
The newest in Journal of Leukemia.
Opinion · 30 Dec 2025
Acute Lymphoblastic Leukemia Management from Conventional Chemotherapy to Precision-Based Treatment Approaches
Opinion · 30 Dec 2025
Stem Cell Transplantation in the Era of Precision Medicine Molecular Insights Therapeutic Strategies and Clinical Applications
Perspective · 30 Dec 2025
The Evolving Landscape of Leukemia Advances in Molecular Biology Immunotherapy and Clinical Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Leukemia
- SubjectHaematology
- BylineArticles whose byline prints “Robert Fran”

